AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Quikhale T 18mcg Respicap

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Tiotropium (18mcg)

Overview Quikhale T 18mcg Respicap

Respicap Quikhale T 18mcg, an anticholinergic medication, treats chronic obstructive pulmonary disease and asthma. By relaxing airway muscles, it eases breathing and alleviates symptoms like wheezing, chest tightness, shortness of breath, and coughing. Administered solely via inhalation, dosage and duration must adhere strictly to your physician's instructions. Initial administration should occur under medical supervision to minimize potential adverse reactions. For optimal efficacy, consistent daily timing is recommended. Dosage frequency is condition-dependent, determined by your doctor to manage your symptoms effectively. Continue using this medication as prescribed. It does not provide immediate relief from an ongoing breathing difficulty or asthma attack; therefore, always carry a rescue inhaler. Dry mouth is a common side effect; report any concerning or persistent side effects to your physician. To combat dry mouth, increase fluid intake, use sugarless candy, or practice diligent oral hygiene. Inform your doctor of any other medications you're using, liver or kidney conditions, or pregnancy/breastfeeding before commencing treatment, as these factors can influence the drug's effectiveness.

Uses of Quikhale T 18mcg Respicap

Managing Chronic Obstructive Pulmonary Disease (COPD)

Major Benefits of Quikhale T 18mcg Respicap:

Follow your doctor's instructions precisely regarding dosage and treatment length. Always refer to the product label for detailed application guidelines.

Common Side effects of Quikhale T 18mcg Respicap:

  • Dryness in mouth

How to use Quikhale T 18mcg Respicap:

Follow your doctor's instructions precisely regarding dosage and treatment length. Always consult the product label prior to administration.

How Quikhale T 18mcg Respicap works:

Respicap Quikhale T (18 mcg) is a bronchodilator belonging to the anticholinergic class. Its mechanism of action involves airway muscle relaxation, leading to increased airway diameter and improved respiratory function.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Quikhale T 18mcg Respicap is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Employing Quikhale T 18mcg Respicap during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Quikhale T 18mcg Respicap while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Closely observe the infant for symptoms such as dehydration, bowel irregularities, and urinary issues.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No drug interactions identified.

LiverLiverNone

No known drug interactions.

What if you forget to take Quikhale T 18mcg Respicap :

Should you forget a Quikhale T 18mcg Respicap dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Quikhale T 18mcg Respicap

LabelValue
Chemical Category Morpholinederivative
Developing Habits No.
Treatment Category Breathing

FAQs on Quikhale T 18mcg Respicap

Quikhale T 18mcg Respicap provides breathing relief within 30 minutes of the first dose. Complete symptom improvement typically occurs within 3 to 7 days.
Quikhale T 18mcg Respicap is not a steroid; it's an anticholinergic medication. It acts by relaxing the small airway muscles, keeping them open for a full 24 hours.
Quikhale T 18mcg Respicap, a long-acting bronchodilator, widens airways for easier breathing. Daily use helps prevent sudden breathing exacerbations and relieves ongoing shortness of breath.
Handle Quikhale T 18mcg Respicap with care to avoid eye contact. Eye contact may cause blurred vision and dilated pupils; consult your doctor if this occurs. Dizziness and blurred vision are also possible side effects; refrain from driving or operating machinery if affected.
This medication may be prescribed for lifelong use because COPD is a chronic condition requiring ongoing treatment.
Rescue medications address sudden disease attacks, while maintenance medications manage symptoms daily. For instance, corticosteroids treat acute shortness of breath from COPD, whereas Quikhale T 18mcg Respicap helps prevent such attacks.
Chronic obstructive pulmonary disease (COPD) is a severe lung condition characterized by narrowed airways, hindering the expulsion of air from the lungs and causing breathing difficulties. COPD encompasses conditions such as chronic bronchitis, involving inflamed airway passages, and emphysema, marked by damaged lung air sacs.
For smokers, quitting is crucial to slowing COPD progression. Continue taking your prescribed medication as directed; consistent use can halt disease progression.
Store Quikhale T 18mcg Respicap at room temperature (68-77°F or 20-25°C), avoiding extreme temperatures and humidity. Do not refrigerate.
Quikhale T 18mcg Respicap
125
MRP 145
13% off